Zhiqiang Shi

Statistics

Publications

Citations

H-Index

Active since

2019

Affiliations

Shandong Tumor Hospital(Current)

Shandong First Medical University

Shandong University

Zhiqiang Shi is an author at Shandong Tumor Hospital specializing in sentinel node-positive breast cancer, adjuvant therapy, and sentinel lymph node status.

ORCID

Publications per year

2019–2024

Publications

Resveratrol promotes skin wound healing by regulating the miR-212/CASP8 axis

Yu Liu, Wu Xiong, Chuwang Wang et al. · Laboratory Investigation · 2021 · 30 citations · Full text

Veterinary Medicine, Dermatology, Molecular Medicine +10

Clinical efficacy and biomarker analysis of neoadjuvant camrelizumab plus chemotherapy for early-stage triple-negative breast cancer: a experimental single-arm phase II clinical trial pilot study

Chunhui Zheng, Yanbing Liu, Xue’er Wang et al. · International Journal of Surgery · 2023 · 19 citations · Full text

Medicine, Oncology, Pharmacology +17

Neo‐adjuvant chemotherapy and axillary de‐escalation management for patients with clinically node‐negative breast cancer

Zhiqiang Shi, Pengfei Qiu, Yanbing Liu et al. · The Breast Journal · 2019 · 14 citations

Medicine, Oncology, Breast Oncology +16

Neoadjuvant therapy and sentinel lymph node biopsy in HER2-positive breast cancer patients: results from the PEONY trial

Xiao Sun, Xueer Wang, Zhao-Peng Zhang et al. · Breast Cancer Research and Treatment · 2020 · 14 citations

Medicine, Oncology, Pathology +17

Sulforaphane reverses the enhanced NSCLC metastasis by regulating the miR-7-5p/c-Myc/LDHA axis in the acidic tumor microenvironment

Zhiqiang Shi, Huiyan Zeng, Bingquan Zhao et al. · Phytomedicine · 2024 · 12 citations

Medicine, Molecular Biology, Oncology +16

1–5 of 5